Liver Diseases, Hepatic Encephalopathy, Hepatic Insufficiency
Conditions
Keywords
Ammonia, Citric acid cycle, Branched Chain Amino Acids
Brief summary
The purpose of this study is to determine whether Branched chain Amino Acids enhances the uptake of ammonia in muscle tissue.
Detailed description
Branched-chain amino acids (BCAA; leucine, valine, isoleucine) are used to prevent hepatic encephalopathy in cirrhotic patients. The main effect of BCAAs is believed to take place in muscles where BCAAs provide carbon-skeletons for the TCA-cycle. This enhances the conversion of alfa-ketoglutarate to ammonia via glutamine. We intend to study the effect of oral administered BCAA on the metabolism of ammonia and amino acids across the leg-muscles by means of catheters inserted into the femoral artery (A) and vein (V). Muscle blood flow (F; L/min) will be determined by constant infusion of indocyanine green and indicator dilution principle. Arterial blood flow and A and V concentrations of ammonia and amino acids will be measured before an oral load of BCAA (0.45 g BCAA/kg body weight) and after 1 and 3 hours. The metabolism of ammonia will also be estimated by means of 13N-NH3 PET scans. Hypothesis: BCAA increases the uptake of ammonia in muscle tissue and lowers arterial ammonia.
Interventions
Branched chain amino acids 0.45g/kg BW. Oral supplement. Administered once on study day
Sponsors
Study design
Eligibility
Inclusion criteria
* 18 patients with liver cirrhosis * 6 healthy subjects age and sex matched
Exclusion criteria
* Non-treated diabetes * Pregnancy/breast-feeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| arterial ammonia concentration | 1 and 3 hours |
Secondary
| Measure | Time frame |
|---|---|
| muscle ammonia metabolism | 1 hour and 3 hours |